Cell growth regulating factor R and its prepn process

A technology of cell growth regulation factors and genes, applied in the field of biomedicine, can solve the problems that cannot be directly put into the human body, and achieve the effect of TC enhancement

Inactive Publication Date: 2007-01-10
谢旭明
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the present inventor finds after this natural cell growth regulating factor (NCGCF) effective original component is used in human body experiment: when simply using the effective original component of the natural cell growth regulating factor series described in the paper, after being used in human body, 4 After -8 hours, you will start to have a fever above 38°C-39°C, and local pain, redness and swelling, so that the effective original component products of the natural cell growth regulator series cannot be directly put into the human body.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0017] Example 2: First, the Gram-negative cocci were screened and the strains were cryopreserved. The strains were routinely cultured at a temperature of 12°C. After the strains were fully cultured, they were filtered three times to remove impurities and harmful bacteria, leaving fragments of beneficial bacteria. , that is, to extract the natural gene; take 1 μg of beneficial bacterial fragments, that is, the natural gene, quantitatively add 3 mg of arginine to it, measure the content and pass the safety test, and seal it under the GMP standard to form a natural cell growth regulator R, After the finished product has passed the inspection, it will be printed and packaged.

Embodiment 3

[0018] Example 3: First, the Gram-negative bacilli were screened and the strains were cryopreserved. The strains were routinely cultured at 20°C. After the strains were fully cultured, they were filtered twice to remove impurities and harmful bacteria, leaving beneficial bacteria. Fragments are the extraction of natural genes; take 1 μg of beneficial bacterial fragments, that is, natural genes, quantitatively add 8 mg of arginine to it, measure the content and pass the safety test, and seal it with water or freeze-dried powder under the GMP standard to form natural cell growth. Control factor R, after the finished product is qualified, it will be printed and packaged.

Embodiment 4

[0019] Example 4: First, the Gram-positive bacilli were screened and the strains were cryopreserved. The strains were routinely cultured at a temperature of 38°C. After the strains were fully cultured, they were filtered once to remove impurities and harmful bacteria, leaving fragments of beneficial bacteria. That is, to extract natural genes, usually the more times of filtration, the purer the beneficial bacterial fragments left after , that is, the natural genes. Take 1 μg of beneficial bacterial fragments, that is, natural gene, quantitatively add 20 mg of arginine to it, measure the content and pass the safety test, and seal it with water under GMP standards to form natural cell growth regulator R. After the finished product is qualified, it will be printed and packaged. .

[0020] Other embodiments of the present invention can be arbitrarily configured within the range of 1 μg of gene and 1 μg of configuration to 500 mg of arginine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention is one kind of natural cell growth regulating factor R and its preparation process. The preparation process includes screening Gram-positive coccus or bacillus and Gram-negative coccus or bacillus, freeze preserving coccus or bacillus strain, conventional culture of the coccus or bacillus strain at 4-38 deg.c, once filtering to eliminate harmful bacteria while leaving beneficial thallus segment, extracting natural gene, adding arginine into the natural gene, safety test, preparing into solution or powder, and sealing. The cell growth regulating factor R has the functions of stimulating and strengthening immunity, strengthening TC, repairing and reforming necrotic, degenerative, atrophic, fibrillated and calcified histiocyte, regenerating capillary vessel, so that it can repair and reform optic nerve cell.

Description

technical field [0001] The invention relates to a medicine beneficial to biological cell growth regulation and a preparation method, and belongs to a kind of biological medicine. Background technique [0002] Human beings, birth, aging, disease and death are a natural law. As human cells age, their regeneration function will gradually lose. The human body enters the aging period, and various cells in the human body decline. more is a good evidence. Human aging is mainly manifested in the cell aging and functional decline of various internal organs. Therefore, in recent years, medical experts from all over the world have been trying to study "longevity drugs" related to prolonging human life. The so-called longevity medicine is nothing more than that this medicine can promote the regeneration of human cells and the enhancement and improvement of the repair ability. However, so far, no documents with similar content of "longevity medicine" have been published. On the other ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/198A61K35/68A61P27/02A61P27/12A61P43/00A61K31/7088A61P25/02A61P37/04
Inventor 谢旭明谢黎升黎景黎智谢昱青朱红
Owner 谢旭明
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap